JP2010509292A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509292A5
JP2010509292A5 JP2009535748A JP2009535748A JP2010509292A5 JP 2010509292 A5 JP2010509292 A5 JP 2010509292A5 JP 2009535748 A JP2009535748 A JP 2009535748A JP 2009535748 A JP2009535748 A JP 2009535748A JP 2010509292 A5 JP2010509292 A5 JP 2010509292A5
Authority
JP
Japan
Prior art keywords
acid
composition
tetrahydrocannabinol
solvent
trans
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009535748A
Other languages
English (en)
Japanese (ja)
Other versions
JP5453096B2 (ja
JP2010509292A (ja
Filing date
Publication date
Priority claimed from US11/595,682 external-priority patent/US8039509B2/en
Application filed filed Critical
Publication of JP2010509292A publication Critical patent/JP2010509292A/ja
Publication of JP2010509292A5 publication Critical patent/JP2010509292A5/ja
Application granted granted Critical
Publication of JP5453096B2 publication Critical patent/JP5453096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009535748A 2006-11-10 2007-11-09 (−)−δ9−トランス−テトラヒドロカンナビノールを含んでなる組成物 Active JP5453096B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/595,682 2006-11-10
US11/595,682 US8039509B2 (en) 2006-11-10 2006-11-10 Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
PCT/EP2007/062174 WO2008055992A1 (en) 2006-11-10 2007-11-09 Composition comprising (-)-δ9-trans-tetrahydrocannabinol

Publications (3)

Publication Number Publication Date
JP2010509292A JP2010509292A (ja) 2010-03-25
JP2010509292A5 true JP2010509292A5 (enExample) 2010-12-24
JP5453096B2 JP5453096B2 (ja) 2014-03-26

Family

ID=39149274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009535748A Active JP5453096B2 (ja) 2006-11-10 2007-11-09 (−)−δ9−トランス−テトラヒドロカンナビノールを含んでなる組成物

Country Status (9)

Country Link
US (4) US8039509B2 (enExample)
EP (1) EP2086954B1 (enExample)
JP (1) JP5453096B2 (enExample)
CN (1) CN101578276A (enExample)
AU (1) AU2007316584B2 (enExample)
CA (1) CA2669021A1 (enExample)
IL (1) IL198651A (enExample)
MX (1) MX2009005003A (enExample)
WO (1) WO2008055992A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980940B2 (en) 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
EP2642982A2 (en) * 2010-11-22 2013-10-02 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8741341B2 (en) * 2012-05-07 2014-06-03 Insys Therapeutics, Inc. Manufacturing and packaging room temperature stable dronabinol capsules
DE102012105063C5 (de) * 2012-06-12 2023-09-14 Thc Pharm Gmbh The Health Concept Stabilisierung von Cannabinoiden und deren pharmazeutischen Zubereitungen
CN103110582A (zh) * 2013-03-04 2013-05-22 上海医药工业研究院 大麻酚类化合物微乳剂及其制备方法
AU2015280412B2 (en) 2014-06-26 2018-07-26 Island Breeze Systems Ca, Llc MDI related products and methods of use
USD772284S1 (en) * 2014-09-01 2016-11-22 Apple Inc. Display screen or portion thereof with a set of graphical user interfaces
JP6676062B2 (ja) 2014-11-03 2020-04-08 ラモト アト テルーアビブ ユニバーシティー リミテッド 認知低下を処置するための方法
USD776682S1 (en) * 2015-09-04 2017-01-17 Salesforce.Com, Inc. Display screen or portion thereof with animated graphical user interface
USD801377S1 (en) * 2015-09-28 2017-10-31 ProductionPro LLC Display panel with transitional graphical user interface
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
CA3072768C (en) 2017-08-27 2024-06-11 Rhodes Technologies Pharmaceutical compositions for the treatment of ophthalmic conditions
CA3173494A1 (en) * 2020-09-24 2022-03-31 Michael Foster DAVIS Cannabinoid composition comprising at least 50% carrier

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726916D0 (en) 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
US6403126B1 (en) 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
GB0112752D0 (en) 2001-05-25 2001-07-18 Johnson Matthey Plc Synthesis of cannabinoids
WO2003006010A1 (en) 2001-07-10 2003-01-23 Norton Healthcare Limited Aerosol formulations of δ8 tetrahydrocannabinol
WO2004000290A1 (en) 2002-06-22 2003-12-31 Norton Healthcare Limited Pharmaceutical composition
PT1542657E (pt) 2002-08-14 2012-02-29 Gw Pharma Ltd Formulações líquidas canabinóides para administração pela mucosa
US20040229939A1 (en) * 2003-02-14 2004-11-18 Chowdhury Dipak K. Tetrahydrocannabinol compositions and methods of manufacture and use thereof
GB0329635D0 (en) 2003-12-23 2004-01-28 Johnson Matthey Plc Process for purifying trans-tetrahydrocannabinol
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
AU2005314021B2 (en) 2004-12-09 2010-02-11 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
ZA200802767B (en) * 2005-09-29 2009-09-30 Amr Technology Inc Process for production of delta-9-tetrahydrocannabinol
EP2046290A4 (en) 2006-08-04 2011-08-17 Insys Therapeutics Inc AQUEOUS DRONABINOL FORMULATIONS
EP1927582A1 (en) 2006-11-07 2008-06-04 Cytec Surface Specialties, S.A. Coatings for ceramic substrates
US8039509B2 (en) 2006-11-10 2011-10-18 Johnson Matthey Public Limited Company Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
WO2009020666A1 (en) 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment

Similar Documents

Publication Publication Date Title
ECSP10010556A (es) Piridinas y pirazinas como inhibidores de pi3k
AR059601A1 (es) Composiciones estables de vitamina c
MX2020003159A (es) Povidona yodada, un conservador alternativo novedoso para composiciones oftalmicas.
CA2582736A1 (en) Anti-aging composition containing phloretin
BRPI0717773A2 (pt) Composto, composição farmacêutica, e, métodos para tratar ou prevenir câncer, uma condição inflamatória, uma condição imunológica ou uma condição metabólica, e para inibir uma quinase em uma célula que expressa a dita quinase
ME00586A (me) Fungicidni azociklični amidi
WO2008132600A3 (en) Trpv1 antagonists and uses thereof
RU2011111206A (ru) Композиции для местного применения, содержащие комбинацию по меньшей мере двух агентов, усиливающих проникновение
ME02147B (me) Jedinjenje sa topikalnom primjenom za aktinične keratoze
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
PE20081365A1 (es) Formulaciones topicas para administracion local que contienen indoxacarb
WO2007129195A3 (en) 4-pyrimidine-5-amino-pyrazole compounds
MA32383B1 (fr) DÉRIVÉS D'INDAZOLES à SUBSTITUTIONS PHÉNYLE ET BENZODIOXYNYLE
RU2009109164A (ru) Фармацевтические композиции, содержащие витамин группы d и кортикостероид
WO2007127725A3 (en) Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods
CR11208A (es) Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas
WO2012071389A3 (en) Stable cannabinoid compositions and methods for making and storing them
ATE549320T1 (de) Neue zubereitung für die äusserliche anwendung
WO2011039444A3 (fr) Composition, utilisation et procédé de conservation
CR9268A (es) Nuevo derivado de diazabiciclononeno
CA2798180A1 (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2012174096A3 (en) Personal care compositions comprising a di-amido gellant and methods of using
WO2014178789A9 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
WO2009004322A3 (en) Derivatives of nystatin and their use as antifungal agents
WO2010106325A3 (en) Parasiticidal formulation